Sinopharm
1099.HK
#2138
Rank
C$10.33 B
Marketcap
$3.31
Share price
1.72%
Change (1 day)
-9.97%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): C$3.25 Billion

According to Sinopharm's latest financial reports the company's current earnings are C$80.09 Billion. In 2024 the company made an earning of C$3.14 Billion a decrease over its 2023 earnings that were of C$4.36 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2024C$3.14 B-27.86%
2023 C$4.36 B-0.73%
2022 C$4.39 B-1.72%
2021C$4.47 B11.7%
2020C$4.00 B18.44%
2019C$3.37 B10.85%
2018C$3.04 B3.05%
2017C$2.95 B36.48%
2016C$2.16 B7.11%
2015C$2.02 B12.38%
2014C$1.80 B25.05%
2013C$1.44 B22.54%
2012C$1.17 B35.43%
2011C$0.86 B52.24%
2010C$0.57 B30.99%
2009C$0.43 B60.59%
2008C$0.27 B48.29%
2007C$0.18 B123.29%
2006C$81.84 M